Key Takeaways
- Record EBITDA margin delivered: Leveraging easing chemical prices and higher volumes, the company posted its best-ever annual EBITDA margin, underscoring its specialty-chemical pricing power.
- Textile segment has turned: After a tough 1.5 years, textile volumes grew at least 20% QoQ, with management calling the recovery and expressing strong excitement for the opportunity ahead.
- A capex cycle is beginning: A new 20,000-ton Phase 1 expansion at the acquired Ambernath land is targeted for FY25 completion, with Phase 2 to follow, laying the infrastructure for a multi-year growth trajectory.
- An inorganic move is in advanced stages: Management is in late-stage diligence on an international acquisition with product-line synergies, signaling a disciplined but imminent capital deployment catalyst.
- What to watch next quarter: The final debt-equity mix for the fundraise, any closure of the international acquisition, and whether the raw material and freight cost uptick pressures the record margin profile.
Margin & Profitability
- Best-ever EBITDA margin: The company leveraged a global easing of chemical prices and higher operating volumes to expand its EBITDA margin to a record level for the year.
- Product mix shift: Modifications in the textile chemicals offering and a changing product mix are structurally improving EBITDA margins and absolute profitability in that segment.
- Gross margin buffer: With gross margins at 39-40%, management sees ample room to absorb rising freight costs and container shortages without damaging profitability.
- Other expenses spike: Q4 other expenses jumped to ~₹14 crores, the highest in 7-8 quarters, driven by sales promotional investments and exhibitions across Bangladesh, China, Frankfurt, and the USA, with results expected in the coming couple of years.
Tibrewala: "I would like to mention we are a solution chemical provider. So, for us turnover is one part of the story, but what makes us is our core focus on the EBITDA margins and EBITDA absolute number growth and that's what our company is focused upon."
Demand & Segment Performance
- Textile recovery underway: After 1.5 years of a tough cycle, textile volumes grew at least 20% QoQ, with management stating good times have arrived and expressing excitement for the opportunities ahead.
- Cleaning & hygiene growth: The segment grew less than 5% QoQ but delivered a strong 25% YoY volume increase, driven by institutional and B2B demand.
- Sustainability as a demand driver: In textiles, reduced water, power, and processing time has been the main business driver for four years. In detergents, foreign MNCs have mandated a shift away from crude oil-based derivatives by 2026-2027, a trend where the company already has selling solutions.
- Import substitution edge: The company competes against European imports by supplying in tanker loads without drums, offering a cost and sustainability advantage versus a 3-month wait for drummed imports.
- Raw material prices turning up: After a downward trajectory, raw material prices are now rising, but the company operates on 2-month purchase orders with a 1-45 day window to pass on price increases.
Tibrewala: "Better days for textile specialty chemicals is around the corner."
Capacity Expansion & Capex
- New Ambernath land acquired: The company acquired 7 acres of factory land at Ambernath MIDC for ₹35 crores, with site work already begun.
- Phase 1 expansion targeted for FY25: A 20,000-ton Phase 1 capacity addition is targeted for completion by the end of FY2025, with updates to be provided via stock exchange disclosures.
- Phase 2 to follow faster: A second 20,000-ton phase is planned and will take less time and cost than Phase 1 because the shared infrastructure will already be in place.
- Fungible capacity strategy: The new facility will cater to textile, home care, cleaning, hygiene, and drilling specialty chemicals, with fungible capacity across all verticals, and will be expanded on a phase-wise basis, replicating the strategy used for the existing Ambernath plant.
- Existing plant utilization: The current Ambernath plant, started three years ago, is already at ~75% utilization, with overall company utilization at ~72% as of Q4.
Tibrewala: "We are looking at already at 2026 time, you know, what are we planning for. So, this investment has been done for increasing our volumes and catering to all the three streams, the three main verticals which we are catering to, which is fungible."
Strategic Initiatives & Inorganic Growth
- International acquisition in advanced stages: Management is in advanced stages of discussions and diligence on an international acquisition with product-line synergies, maintaining a disciplined focus on ROCE and ROE.
- Fundraise underway: The first tranche of a ~₹120 crore fundraise is in progress, with ₹55 crores already raised from the promoter's family, increasing promoter stake by 1.2%.
- Debt-equity mix open: Management is not averse to taking debt and will finalize the debt versus equity component of the fundraise in the coming few months or fortnight.
- India as a specialty chemical hub: Management sees Western companies increasingly eyeing India for joint ventures and partnerships, and wants to be ahead with structures and infrastructure ready to capture this shift.
- Sales investments seeding future growth: Current exhibition and travel investments are laying seeds, with results expected in the coming couple of years.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Phase 1 capacity expansion | 20,000 tons of new capacity commissioned | By end of FY2025 |
| Phase 2 capacity expansion | Additional 20,000 tons planned, faster and cheaper than Phase 1 | No timeline given |
| Inorganic acquisition | International acquisition with product-line synergies, disciplined on ROCE/ROE | In advanced stages; no closure timeline given |
| Growth trajectory | Percentage growth achieved in last 4-5 years "can be surely done in the next 4-5 years" | Next 4-5 years |
| Fundraise structure | Final debt vs. equity mix to be decided | In coming few months or fortnight |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Operations revenue | ₹153 crore |
| Operations revenue (FY2024) | ₹569 crore |
| EBITDA | ₹38.3 crore, 17.1% YoY increase |
| EBITDA margin | 25% |
| Profit after tax | ₹30.5 crore, 17.2% YoY growth |
| PAT margin | 19.9% |
| EBITDA (FY2024) | ₹148.4 crore, 31.8% YoY growth |
| EBITDA margin (FY2024) | 26.1% |
| PAT (FY2024) | ₹121 crore, historic highest, up 35.1% YoY |
| PAT margin (FY2024) | 21.3% |
| ROCE | 34.3% |
| ROE | 29.9% |
| Total dividend FY2024 | ₹1.60 per share, including final dividend of ₹0.40 per share |
| Total volume growth | 25% YoY |
| Textile volume growth | At least 20% QoQ |
| Cleaning and hygiene volume growth | Less than 5% QoQ |
| Volume contribution split (full year) | 45% textiles, 55% cleaning and hygiene specialties |
| Capacity utilization | ~72%, 76,000 tons utilized of 104,000 tons total capacity |
| Phase 1 capacity expansion | At least 20,000 tons, expected by financial year end |
| New plant capex (Phase 1) | ₹35 crore deployed for land and building, out of ~₹50 crore total planned |
| Fundraise | ₹120 crore broadly, ₹55 crore already raised from promoter family |
| Gross margin | ~39-40%, average for last 6-8 quarters |